Jun Gong Selected Research

Advanced Glycation End Products

7/2019	Phloretin and its methylglyoxal adduct: Implications against advanced glycation end products-induced inflammation in endothelial cells.
1/2019	Apigenin and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Gong Research Topics

Disease

84	Neoplasms (Cancer) 04/2024 - 01/2008
20	Adenocarcinoma 11/2023 - 10/2007
17	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 12/2011
16	Inflammation (Inflammations) 11/2023 - 09/2006
13	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2016
13	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 01/2016
11	Stomach Neoplasms (Stomach Cancer) 03/2024 - 02/2006
11	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 04/2017
10	Carcinogenesis 03/2024 - 10/2007
10	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 11/2011
10	Microsatellite Instability 01/2023 - 01/2017
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2018
7	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 01/2016
7	Insulin Resistance 01/2019 - 02/2010
5	Disease Progression 04/2024 - 01/2020
5	Adenocarcinoma of Lung 03/2024 - 07/2016
5	Infections 09/2023 - 03/2004
5	Non-alcoholic Fatty Liver Disease 11/2018 - 01/2014
5	Cardiomegaly (Heart Hypertrophy) 01/2018 - 05/2016
5	Metaplasia 12/2010 - 04/2004
4	Breast Neoplasms (Breast Cancer) 12/2023 - 03/2015
4	Rectal Neoplasms (Rectal Cancer) 06/2022 - 01/2020
4	Turcot syndrome 06/2022 - 01/2019
4	Fatty Liver 01/2019 - 01/2017
4	Obesity 11/2018 - 06/2004
4	Fibrosis (Cirrhosis) 01/2018 - 10/2002
4	Gastroesophageal Reflux (GERD) 12/2010 - 11/2004
3	Liver Neoplasms (Liver Cancer) 02/2024 - 12/2019
3	Hypertension (High Blood Pressure) 11/2023 - 01/2021
3	COVID-19 10/2023 - 01/2020
3	Carcinoma (Carcinomatosis) 01/2023 - 02/2006
3	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2019
3	Esophageal Neoplasms (Esophageal Cancer) 02/2022 - 09/2005
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2019
3	Liver Diseases (Liver Disease) 01/2019 - 04/2017
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 09/2013
3	Ischemic Stroke 12/2017 - 08/2015
3	Atherosclerosis 02/2017 - 01/2017
3	Myoma 02/2011 - 07/2008
2	Hemorrhage 11/2023 - 08/2009
2	Pathologic Processes 01/2023 - 01/2020
2	Pneumonia (Pneumonitis) 01/2023 - 01/2022
2	Leiomyoma (Uterine Fibroids) 12/2022 - 02/2011
2	Pain (Aches) 12/2022 - 07/2019
2	Hyperglycemia 12/2022 - 01/2014
2	Lung Neoplasms (Lung Cancer) 12/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
17	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2007
12	pembrolizumabIBA 01/2023 - 01/2017
9	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
8	Long Noncoding RNAIBA 11/2023 - 10/2016
8	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2014
6	Messenger RNA (mRNA)IBA 09/2022 - 01/2004
6	B7-H1 AntigenIBA 01/2021 - 01/2018
5	Glutamine (L-Glutamine)FDA Link 03/2024 - 01/2021
5	CateninsIBA 09/2022 - 01/2017
5	AcidsIBA 02/2022 - 11/2004
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2024 - 05/2020
4	Androgen Receptors (Androgen Receptor)IBA 11/2023 - 01/2020
4	AndrogensIBA 11/2023 - 01/2020
4	Circulating Tumor DNAIBA 01/2023 - 01/2019
4	Insulin (Novolin)FDA Link 12/2022 - 02/2010
4	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 01/2014
4	RNA (Ribonucleic Acid)IBA 11/2022 - 10/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2019 - 01/2016
4	LipidsIBA 01/2019 - 01/2016
4	TOR Serine-Threonine KinasesIBA 10/2016 - 01/2014
3	erdafitinibIBA 04/2024 - 10/2022
3	trametinibIBA 01/2024 - 01/2022
3	ErbB Receptors (EGF Receptor)IBA 12/2023 - 10/2016
3	VaccinesIBA 10/2023 - 12/2021
3	BilirubinIBA 09/2023 - 04/2002
3	Gemcitabine FDA Link 05/2023 - 04/2017
3	N-methyladenosineIBA 01/2023 - 01/2020
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 01/2017
3	Leucovorin (Folinic Acid)FDA Link 11/2022 - 01/2020
3	Hyaluronic Acid (Hyaluronan)IBA 11/2022 - 01/2022
3	Fluorouracil (Carac)FDA LinkGeneric 09/2022 - 01/2017
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2014
3	NivolumabIBA 05/2020 - 01/2018
3	Phosphotransferases (Kinase)IBA 06/2019 - 11/2008
3	Ethanol (Ethyl Alcohol)IBA 01/2019 - 10/2010
3	Hormones (Hormone)IBA 04/2018 - 01/2014
2	Essential Amino AcidsIBA 03/2024 - 01/2023
2	dabrafenibIBA 01/2024 - 01/2023
2	AntibodiesIBA 10/2023 - 01/2018
2	AlbuminsIBA 09/2023 - 01/2023
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2023
2	UbiquitinIBA 01/2023 - 12/2017
2	COVID-19 VaccinesIBA 12/2022 - 12/2021

Therapy/Procedure

57	Therapeutics 03/2024 - 07/2009
26	Drug Therapy (Chemotherapy) 05/2024 - 09/2013
21	Immunotherapy 03/2024 - 01/2018
10	Radiotherapy 05/2024 - 03/2015
6	Neoadjuvant Therapy 12/2023 - 01/2018
4	Adjuvant Chemotherapy 07/2022 - 01/2017
3	Ligation 11/2023 - 07/2008
3	Pancreaticoduodenectomy 04/2021 - 01/2012
3	Castration 01/2021 - 11/2011
2	Precision Medicine 03/2024 - 01/2019